Below you can find examples of SYNLAB’s engagement across Europe and beyond highlighting the Group’s contribution in the fight against the virus.

Recent medical releases | SARS-CoV-2
  • Antibody monitoring allows to determine the amount of neutralizing anti-S1 specific antibodies which correlate with the human body’s level of protection against SARS-CoV-2
  • The amount of neutralizing anti-S1 specific antibodies continuously decreases after vaccination
  • Antibody monitoring is particularly helpful for immunosuppressed patients and elderly people since their…
Read more
SARS-CoV-2

Video report by RBB on the gargle test for the detection of COVID-19 infection in the SYNLAB laboratory in Berlin.

Simple gargling as an alternative to the somewhat unpleasant nasal swab? The gargle variant of the Corona test is becoming increasingly popular in our laboratories. Why this is so is shown in a report by RBB, which takes us from the Berlin Volksbühne to the SYNLAB…

 Read more
Recent medical releases | SARS-CoV-2

SYNLAB, the leading medical diagnostic services provider in Europe, emphasizes that negative rapid antigen test results must not lead to a reduction of precautionary measures nor grant access to safe environments.

Read more
SARS-CoV-2

The coronavirus mutates 23 times. So far, variants from Brazil, Great Britain and South Africa have caused great concern. In order to localise them more quickly, more swabs have been examined for mutations since January. Please click here to watch the video.

 Read more
Recent medical releases | SARS-CoV-2
  • Through the worldwide spread of the SARS-CoV-2 virus, its RNA sequences changed, causing the initiation of hundreds of new mutant variants of the initial virus
  • SYNLAB uses its long-standing expertise to respond to the public health authorities’ demand for sequencing positive test results, contributing to monitoring the development of the virus and the spread of more…
Read more
Recent medical releases | SARS-CoV-2
  • New SYNLAB data confirm that almost 40% of cases tested positive for SARS-CoV-2 with PCR testing could have been missed when using rapid antigen tests.
  • A direct comparison between PCR and rapid antigen tests highlights the low sensitivity of rapid antigen tests based on medical data from SYNLAB’s safe-at-work testing.
  • These studies indicate that rapid antigen tests cannot…
Read more
SARS-CoV-2 | Press releases

Alternative sampling method for SARS-CoV-2 PCR tests based on saliva instead of conventional nasopharyngeal or oropharyngeal swab or mouthwash sampling.

Read more
SARS-CoV-2 | Press releases

SYNLAB implements non-invasive pain-free sampling method
 

Read more
SARS-CoV-2 | Press releases
  • Over the course of the past six months, SYNLAB has been responding to requests for testing from different EU countries.
  • Recently, SYNLAB entered into an agreement with the Ministry of Health, Welfare and Sport of the Kingdom of the Netherlands to provide increasing capacities for SARS-CoV-2 RT-PCR testing.


SYNLAB, the leading medical diagnostic services provider in…

Read more
SARS-CoV-2

One of the leading companies in the sector warns that they tend to give false negatives in people with lower amounts of virus and point out that they are only reliable in those with high viral load

 Read more